Maurício Maia - Concepedia

Author

Maurício Maia

Also Known As

Francisco Jose Rodriguez, J. Fernando Arevalo, Liliane Andrade Almeida Kanecadan, M Maia, M. Farah, M. Maia, M. Tameesh, MAURICIO MAIA, MAURÍCIO MAIA, Maia, Mauricio

418

Publications

12.4K

Citations

H-Index

Concepts

All Affiliations

Universidade Federal de São Paulo Instituto da Visão Johns Hopkins University University of Puerto Rico System Johns Hopkins Medicine

About

Maurício Maia is an author at Universidade Federal de São Paulo specializing in medicine, ophthalmology, and glaucoma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	38	2.7K
2	Public Health	2	2	141
3	Social Sciences	2	2	159
4	Health Sciences	1	1	11
5	Anesthesia	1	1	91

Maurício Maia

125

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
Ocular Findings in Infants With Microcephaly Associated With Presumed Zika Virus Congenital Infection in Salvador, Brazil Bruno de Paula Freitas, João Rafael de Oliveira Dias, Juliana Prazeres, JAMA Ophthalmology	2016	566
Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES) Lihteh Wu, María Ana Martinez-Castellanos, Hugo Quiroz–Mercado, Graefe s Archive for Clinical and Experimental Ophthalmology Ocular DiseaseVitreous BodyExperimental OphthalmologyOphthalmologyIntravitreal Injections	2007	454
Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy J. Fernando Arévalo, Maurício Maia, Harry W. Flynn, British Journal of Ophthalmology	2007	404
Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD Robert L. Avery, Alessandro Castellarin, Nathan Steinle, British Journal of Ophthalmology	2014	362
Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema J. Fernando Arévalo, Jans Fromow-Guerra, Hugo Quiroz–Mercado, Ophthalmology Diabetic RetinopathyOcular DiseaseOphthalmologyDiabetesPrimary Intravitreal Bevacizumab	2007	335
SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB Robert L. Avery, Alessandro Castellarin, Nathan Steinle, Retina	2017	318
Ophthalmological findings in infants with microcephaly and presumable intra-uterus Zika virus infection Camila V. Ventura, Maurício Maia, Bruna V. Ventura, Arquivos Brasileiros de Oftalmologia	2016	300
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi, The Lancet Clinical EpidemiologyClinical TrialsGeographic AtrophyPharmacotherapyAvacincaptad Pegol	2023	263
Subretinal Implantation of Retinal Pigment Epithelial Cells Derived From Human Embryonic Stem Cells: Improved Survival When Implanted as a Monolayer Bruno Diniz, Padmaja B. Thomas, Biju B. Thomas, Investigative Ophthalmology & Visual Science	2013	240
Risk Factors Associated With the Ophthalmoscopic Findings Identified in Infants With Presumed Zika Virus Congenital Infection Camila V. Ventura, Maurício Maia, Simone Travassos, JAMA Ophthalmology	2016	178

Page 1